Navigation Links
Herley New England Receives Additional $1.3 Million Contract Award from Lockheed Martin for the Multi-Mission Helicopter
Date:9/29/2008

LANCASTER, Pa., Sept. 29 /PRNewswire-FirstCall/ -- Herley Industries, Inc. (Nasdaq: HRLY) announced today that its Herley New England division in Woburn, Massachusetts, has a contract totaling approximately $1.3 million from Lockheed Martin Systems Integration, Owego, NY, for the manufacture of complex switch filter assemblies for the MH-60R helicopter in an electronic support measures ("ESM") system.

The MH-60R Multi-Mission Helicopter (MMH) is the U.S. Navy's new primary maritime-dominance helicopter, replacing the SH-60B and SH-60F aircraft. The MH-60R is designed primarily for anti-submarine and anti-surface warfare. Secondary missions include search and rescue, vertical replenishment, naval surface fire support, logistics support, personnel transport, medical evacuation and communications and data relay.

Lockheed Martin, the prime air weapons systems integrator for the MH-60R, announced a multi-year contract last year under which it will integrate advanced electronic systems into 139 multi-mission helicopters through 2013.

Herley Chairman and CEO, Myron Levy, commented, "We are very pleased that Herley New England continues to support Lockheed Martin on this important long-term program. This award is a follow on to awards received on this program last year."

Herley Industries, Inc. is a leader in the design, development and manufacture of microwave technology solutions for the defense, aerospace and medical industries worldwide. Based in Lancaster, PA, Herley has eight manufacturing locations and approximately 1000 employees. Additional information about the company can be found on the Internet at http://www.herley.com.
For information at Herley contact: Tel: (717) 735-8117

Peg Guzzetti http://www.herley.com

Investor Relations

Safe Harbor Statement - Except for the historical information contained herein, this release may contain forward-looking statements. Such statements are inherently subject to risks and uncertainties. When used in this report, words such as "anticipated," "believes," "could," "estimates," "expects," "may," "plans," "potential" and "intends" and similar expressions, as they relate to the Company or its management, identify forward-looking statements. Such forward-looking statements are based on the belief of the Company's management, as well as assumptions made by and information currently available to the Company's management. The Company's results could differ materially based on various factors, including, but not limited to, cancellation or deferral of customer orders, difficulties in the timely development of new products, difficulties in manufacturing, increased competitive pressures, and general economic conditions. The Company undertakes no obligation to update forward-looking statements as a result of future events or developments.


'/>"/>
SOURCE Herley Industries, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Herley Reports 4th Quarter and Year-End Results
2. Herley Industries, Inc. Receives a $5 Million Award from EDO for Electronic Components for IEDs
3. Herley Industries Announces the Passing of Its Former President
4. Herley Industries, Inc. Second Quarter Earnings Release and Conference Call Notice
5. Herley Reports Second Quarter Results
6. Herley Awarded $1 Million in Awards for Integrated Microwave Assemblies for U.S. Military Aircraft
7. Herley Announces Settlement Agreement with U.S. Government
8. Herley Reports Third Quarter Results
9. Herley Industries, Inc. Engages Jefferies Quarterdeck to Explore Strategic Alternatives
10. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
11. Benjamin England, Former FDA Regulatory Counsel, to Testify on FDA Import Strategic Plan Before House Appropriations Subcommittee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... 31, 2016 , ... Phynd Technologies, Inc. announced recently the signing of three ... and Shore Medical Center – Somers Point, NJ. The new clients range in bed ... the breadth of Phynd’s solution and its interoperability. , Houston Methodist is a leading ...
(Date:5/31/2016)... ... May 31, 2016 , ... In a recent interview ... and broadcast on New Rochelle, NY-based WVOX (1460 AM), leading medical insurance ... she calls the country’s “modern medical money maelstrom.” , During the interview with ...
(Date:5/31/2016)... ... ... Dr. Charles A. Ditta attained his Doctor of Medical Dentistry Degree from ... where he graduated in the top ten percentile of his class. Dr. Ditta has ... has been a member in good standing for thirty years in the American Dental ...
(Date:5/31/2016)... ... May 31, 2016 , ... To meet ... to the healthcare industry, The University of Scranton is adding a Certificate in ... to a career in rapidly growing field of healthcare information. , Healthcare ...
(Date:5/31/2016)... , ... May 31, 2016 , ... Super Powder, a ... to on the go individuals and dedicated athletes, continues to transform the nutritional supplement ... with whey, pea and milk protein, branched-chain amino acids (BCAA), alkaline minerals, wheat grass, ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. (OTCQX: AMBS), ... Neurology and Orphan Diseases, today announced that President & CEO ... conferences: SeeThru Equity MicroCap Conference   ... City , NY When: Tuesday, May 31 st ... Where: Grand Hyatt Hotel, 109 East 42 nd ...
(Date:5/26/2016)... May 26, 2016   Change Healthcare ... analytics, network solutions and technology-enabled services designed ... entered into a strategic channel partnership with ... software solutions and revenue cycle management services ... and rehabilitation clinics to optimize revenue, operational ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May ... QGEN ; Frankfurt Prime Standard: QIA) today announced that ... with Therawis Diagnostics GmbH to develop and commercialize predictive assays ... market PITX2 as a marker to predict effectiveness of anthracycline ... "We are pleased to partner with Therawis, which ...
Breaking Medicine Technology: